INDEX OF PHARMACOPOEIAS - World Health Organization
Working document QAS/11.453/Rev.2(Previous reference: WHO/PSM/QSM/2006.2)August 2013Original: EnglishINDEX OF PHARMACOPOEIASThe Index of Pharmacopoeias has been circulated to national pharmacopoeia commissions for their feedback and thedata received from them have been used to update the list. Links to online pharmacopoeias have been providedwhere available. Where no specific links to online pharmacopoeias are available, links to organizations of nationalpharmacopoeia commissions are listed.The list is provided for reference purposes only and does not pretend to be complete.In order to bring this list up to date we would appreciate any additional data you may have. Please address yourobservations to Dr Sabine Kopp, Medicines Quality Assurance Programme, Quality Assurance & Safety: Medicines,Essential Medicines and Health Products, World Health Organization, 1211 Geneva 27, Switzerland; fax: (0041 22)791 47 30 or e-mail: kopps@who.int.Index of pharmacopoeias World Health Organization 2013All rights reserved.
Working document QAS/11.453/Rev.2page 2Table of contentspageI. NATIONAL 20.21.22.23.24.25.Argentina. 4Austria . 5Belarus . 5Belgium . 5Brazil . 6China . 6Croatia. 7Czech Republic . 7Denmark . 8Egypt . 9Finland . 9France . 9Germany . 10Greece . 11Hungary . 11Iceland . 11India . 12Indonesia . 12Iran . 13Ireland . 13Italy . 13Japan . 14Kazakhstan . 16Korea. 15Lithuania . 16
Working document QAS/11.453/Rev.2page 2.43.44.45.46.Mexico . 16Montenegro . 17Norway . 17Pakistan . 18Philippines . 18Poland . 19Portugal. 19Serbia . 20Romania . 20Russian Federation. 21Slovakia . 21Slovenia . 22Spain . 22Sweden . 22Switzerland . 23Thailand . 23Turkey . 24Ukraine. 24United Kingdom . 25United States of America. 25Viet Nam . 256II. REGIONAL AND SUBREGIONAL . 2647. Europe . 25648. Africa . 257III. INTERNATIONAL . 2849. WHO, Geneva . 28
Working document QAS/11.453/Rev.2page 4I. NATIONALCOUNTRYTITLE1. PHARMACOPOEIA COMMISSIONS2. PUBLISHER/DISTRIBUTOR3. ONLINE ACCESS ADDRESS4. FREQUENCY OF PUBLICATIONEDITIONYEAR LANGUAGEArgentinaFarmacopea Argentina1. & 2. Farmacopea ArgentinaAdministración Nacional de Medicamentos,Alimentos y Tecnología Médica (ANMAT)Avenida de Mayo 869 (C1084AAD) - CiudadAutónoma de Buenos Aires, ArgentinaWeb site: http://www.anmat.gov.ar (Spanish)E-mail: fa@anmat.gov.ar8th Edition* (vol.1,2,3,4)7th Edition, vol.16th Edition5th Edition4th Edition3rd Edition2nd Edition1st Edition20112002197819661956194319211893* the content that is onpublic consultation since20113. Farmacopea Argentina7th Edition (Volume1)http://www.anmat.gov.ar/fna/septima edicion.htm(Spanish)(only one volume approved and published (vol.1). The online access address of 7th edition are justthe index of the approved vol. 1 and the contentintended to be included in the vol. 2 and vol. 3 thatwere not published.)8th Edition (Volumes 1, 2, 3, 4)Web site:http://www.anmat.gov.ar/webanmat/fna/octava edicion.asp (Spanish)(the content is on public consultation since 2011)Spanish
Working document QAS/11.453/Rev.2page 5AustriaÖsterreichischesArzneibuch (ÖAB)(Austrian Pharmacopoeia)1. Österreichische ArzneibuchkommissionBundesministerium für GesundheitRadetzkystr.2, A -1031 WienWeb site: http://www.bmg.gv.at (English, German)E-mail: pamela.rendi-wagner@bmg.gv.atOfficial Edition2011German1st Edition, vol. 1vol. 2vol. 3200620082009Russian2. Verlag Österreich GmbH,Bäckerstr. 1, A – 1010 html4. �акопеи РеспубликиБеларусь(State Pharmacopoeia ofthe Republic of Belarus)1. The Pharmacopoeial-and-Pharmaceutical AnalysisLaboratory of the Centre for Expertise and Testing inHealth Care,The Ministry of Health of the Republic ofBelarus2a Tovarishesky Lane, Minsk, 220037, BelarusWeb site: http://www.rceth.by/lffaeng.htm (Russian,English)E-mail: info@rceth.by2. Ministry of Health of the Republic of Belarus220048, Minsk, Miasnikov street, 39Belgium1. Belgian Pharmacopoeia CommissionFederal Agency for Medicines and Health ProductsEUROSTATION Building, Block 2place Victor Horta, 40/ 40B-1060 BrusselsWeb site: http://www.fagg-afmps.be (Dutch, English,French)E-mail: moise.essoh@afmps.be
Working document QAS/11.453/Rev.2page 6BrazilFarmacopéia Brasileira1. & 2. Agência Nacional de Vigilância Sanitária –ANVISAFarmacopéia BrasileiraSIA, Excerpt 5, 57 Special AreaCidade: Brasília - DFCity: Brasília - DFCEP: 71.205-050, BrazilWeb site: http://www.anvisa.gov.br (Portuguese)E-mail: farmacopeia@anvisa.gov.br5th Edition, Vols 1, 24th EditionPart 1Part 2, Vol. 1Vol. 2Vol. 3Vol. 4Vol. 5Vol. 63rd Edition2nd Edition1st Edition2010Portuguese3rd Edition2nd Edition1st Edition201119971976Portuguese9th Edition8th Edition7th Edition201020052000Chinese, EnglishChinese, EnglishChinese, English19881996200020022003200420051976195719293. Farmacopéia Brasileirahttp://www.anvisa.gov.br/hotsite/cd farmacopeia/index.htm (Portuguese)FarmacopeiaHomeopática Brasileira(Brazilian HomeopathicPharmacopoeia)1,2. see above3. Farmacopéia Homeopática ileira/conteudo/3a edicao.pdf (Portuguese)China1. Chinese Pharmacopoeia CommissionState Food and Drug AdministrationBuilding 11 Fahua Nan li, Chongwen District, 100061Beijing, ChinaWeb site: http://www.chp.org.cn (Chinese)E-mail: chpc@chp.org.cnPharmacopoeia of thePeople's Republic ofChina2. China Medico-Pharmaceutical Science &Technology Publishing Househttp://www.cmstp.com
Working document QAS/11.453/Rev.2page 7A-22, Northern WenHuiYuan Road, Haidian District,Beijing 100082, P. R. China4. once every five yearsCroatia6th Edition5th Edition4th Edition3rd Edition2nd Edition1st Edition199519901985197719631953Chinese, EnglishChinese, EnglishChinese, EnglishChineseChineseChinese2007Croatian1. Pharmacopoeia CommissionAgency for Medicinal Products and Medical Devices ofCroatiaKsaverska cesta 410 000 Zagreb, CroatiaWeb site: http://www.halmed.hr (Croatian, English)E-mail: halmed@halmed.hrHrvatska Farmakopeja(CroatianPharmacopoeia)2. Croatian Pharmaceutical Society(Hrvatsko Farmaceutsko Društvo)Masarykova 2, 10000 Zagreb, CroatiaWeb site: http://www.hfd-fg.hr/about us.asp (Croatian,English)E-mail: hfd-fg-ap@zg.t-com.hr3. Hrvatska eni/297531.htmlCzechRepublicCroatian1. Pharmacopoeia CommissionState Institute for Drug ControlMinistry of Health of the Czech RepublicŠrobárova 48,100 41 Praha 10, Czech RepublicWeb site: http://www.sukl.eu (Czech, English)E-mail: posta@sukl.czČeský lékopis2. Vydala Grada Publishing a.s. U Pruhonu 466/22,Praha 7-Holešovice, Jako svou 1739. publikaciEdition (MMIX)Supplement20092010Czech
Working document QAS/11.453/Rev.2page 8ABOVE ADDRESS AT 2. NOT IMPORTANT,PRINTER ONLY201120122013Edition (MMV)Supplement 1Supplement 2Edition (MMII)Supplement 1Supplement 2Supplement 3Edition (MCMXCVII)Supplement 1Supplement 2Supplement 34th EditionSupplement3rd Edition, Vol. 1,Vol. 2Supplement2nd EditionSupplement1st EditionSupplementDenmark1. Danish Pharmacopoeia CommissionDanish Medicines AgencyAxel Heides Gade 1DK-2300 København SWeb site:http://www.dkma.dk (Danish, English)E-mail: 012)(1.9.2013)4th edition is the lastauthentic and teamworkpharmacopoeia for theCzech Republic andSlovakia
Working document QAS/11.453/Rev.2page 9EgyptEgyptian Pharmacopoeia1. Permanent Commission of the EgyptianPharmacopoeia,The Egyptian Drug Authority21 Abd El-Aziz Al Soud Street, El-Manial, Cairo, EgyptWeb site: http://www.eda.mohp.gov.eg (Arabic,English)E-mail: plan.imp@eda.mohealth.gov.eg4th Edition3rd Edition2nd Edition1st Edition2005198419721953Arabic, English2. Wolters Kluwer France1 rue Eugène et Armand Peugeot92856 Rueil-Malmaison cedex10th Edition2010French(Some updated texts arein English)4. undated yearly, Since 1998, the French11th Edition (online)April2. General Organization for Government PrintingOffice, CairoFinland1. FIMEA Pharmacopoeia CommitteeLääkealan turvallisuus- ja kehittämiskeskusFinnish Medicines Agency (FIMEA)P.O. Box 55, Mannerheimintie 103b, FI-00301HelsinkiWeb site: http://www.fimea.fi (Finnish, Swedish,English)E-mail: communications@fimea.fiFrance1. Commission nationale de pharmacopéeAgence Française de Sécurité Sanitairedes Produits de Santé–Direction des Laboratoireset des Contrôles, Unité PharmacopéeAfssaps143/147, bd Anatole FranceF- 93285 Saint Denis cedexWeb site:http://www.afssaps.fr frPharmacopée française
Working document QAS/11.453/Rev.2page 10Pharmacopoeia consists of three folders regularlyupdatedGermany20121. Deutsche Arzneibuch-Kommission,Bundesinstitut für Arzneimittel und Medizinprodukte(Federal Institute for Drugs and Medical Devices)Kurt-Georg-Kiesinger-Allee 3, D-53175 BonnWeb site: http://www.bfarm.de (English, German)E-mail: Arzneibuch@bfarm.deDeutsches Arzneibuch(DAB)2. Deutscher Apotheker Verlag, StuttgartMedpharm GmbH Scientific Publishers,Birkenwaldstraβe 44, D-70191Stuttgart4. updated yearly.In accordance with Section 55 of the PharmaceuticalsAct (Arzneimittelgesetz - AMG), the Pharmacopoeiaand the date of entry into force of the revised version.DeutschesHomoeopathischesArzneibuch(HAB)1. Deutsches Homöopathisches ArzneibuchBundesinstitut für Arzneimittel und MedizinprodukteKurt-Georg-Kiesinger-Allee 3, D-53175 BonnWeb site:http://www.bfarm.de (English, German)E-mail: Arzneibuch@bfarm.de4. yearly.2. Deutscher Apotheker Verlag, StuttgartGovi-Verlag- Pharmazeutischer Verlag GmbH,EschbornDAB 2011DAB 2010DAB 1997-2009German6th Edition5th Edition4th Edition3rd Edition2nd Edition1st 0189018831872HAB 2011HAB 201020112010German10th Edition9th Edition8th Edition7th Edition
Working document QAS/11.453/Rev.2page 11GreeceGreek Pharmacopoeia1. Greek Pharmacopoeia Commission NationalOrganization for MedicinesLaboratory DivisionPharmacopoeia SectionMesogeion Avenue, 284GR-15562 Holargos AttikisWeb site: http://www.eof.gr (English, Greek)E-mail: president@eof.gr5th Edition, vols 1, 2Supplement 1Supplement 2Supplement 3Supplement 419982000200220062009Greek8th Edition7th Edition6th Edition5th Edition4th Edition3rd Edition2nd Edition1st Edition20061987196719581933190918881871Hungarian2. National Organisation for Medicines,Mesogeion Street, 28415562 Holargos AttikisGreeceHungaryMagyar gyógyszerkönyv(PharmacopoeiaHungarica)1. Hungarian Pharmacopoeia Commission (OGYI)National Institute of PharmacyH-1051 Budapest, Zrínyi utca 3,Levélcím: 1372 Postafiók 450.Web site:http://www.ogyi.hu/ (Hungarian, English)E-mail: gyogyszerkonyv@ogyi.hu2. Medicina konyvkiado, Budapesthttp://www.medicina-kiado.huIceland1. The Icelandic Medicines Agency (IMA)LyfjastofnunVinlandsleid 14113, Reykjavík, IcelandWeb site: www.lyfjastofnun.is (Icelandic, English)E-mail: ima@ima.is
Working document QAS/11.453/Rev.2page 12IndiaIndian Pharmacopoeia(IP)1.& 2. Office of The Secretary-cum-Scientific DirectorIndian Pharmacopoeia CommissionMinistry of Health and Family WelfareGovernment of IndiaSector-23, Raj Nagar, Ghaziabad-201 002, IndiaWeb site: http://www.ipc.nic.in (English)E-mail: ipclab@vsnl.net3. Indian Pharmacopoeiahttp://ipc.nic.in/usermain.asp4. BiannuallyIndonesiaFarmakope Indonesia1. Indonesian Pharmacopoeia CommissionDirectorate of Therapeutic Products and HouseholdHealthcare StandardizationNational Agency of Drug and Food ControlKesehatan R.I., Jl, PercetakanNegara 23, Jakarta 10560Web site: http://www.pom.go.id (Indonesian)E-mail: Informasi@pom.go.id; suadrif.1@gmail.com2. Kementerian Kesehatan, Republik Indonesia(Ministry of Health, Republic of Indonesia)DJL. KuninganJakarta7th Edition6th EditionAddendum5th EditionAddendum4th EditionSupplement (Vet)AddendumAddendum3rd EditionSupplementSupplement2nd EditionSupplement1st 0051985198919911966197519551960English4th Edition3rd Supplement ofPharmacopoeiaIndonesia2nd Supplement ofPharmacopoeiaIndonesia1st Supplement an20102009
Working document QAS/11.453/Rev.2page 13IranIranian PharmacopoeiaIrelandItaly1. Iranian PharmacopoeiaDrug Administration of Iran, Division ofPharmaceuticals & Narcotic AffairsMinistry of Health and Medical EducationP.O.Box 310,Teheran 11344, Islamic Republic of IranLocation: 14th floor, MOHME building, Simaye IranStreet, Phase 5, Shahrake Qods, Teheran, Iran(Islamic Republic of)Web site: http://www.mohme.gov.ir (Arabic)E-mail: Lankarani@mohme.gov.ir1st Edition2013Persian12th Edition11th EditionSupplement (2005)20082002Italian1. Irish Medicines BoardKevin O'Malley House,Earlsfort Centre,Earlsfort Terrace,Dublin 2,IrelandWeb site:http://www.imb.ie (English)E-mail: imb@imb.ieFarmacopea Ufficialedella Repubblica Italiana1. Permanent Commission of the ItalianPharmacopoeia, Istituto Superiore di SanitàViale Regina Elena 299I-00161 - Roma (I)Web site:http://www.iss.it (English, Italian)E-mail:Farmcp@iss.it2. Ministerio della Salute,Commissionepermanente per la revisione e pubblicazionedella Farmacopea Ufficiale,Istituto Poligrafico e Zecca dello Stato P.V.,I-1213045 Roma
Working document QAS/11.453/Rev.2page 14JapanThe JapanesePharmacopoeia (JP)1. Expert Committee on the Japanese PharmacopoeiaPharmaceuticals and Medical Devices AgencyShin-kasumigaseki Building,3-3-2, Kasumigaseki,Chiyoda-ku,Tokyo 100-0013JapanWeb site: http://www.pmda.go.jp/english/index.html(Japanese, English)E-mail: Std-jpenghp@pmda.go.jp2. Committee on the Japanese Pharmacopoeia/Pharmaceutical Affairs Food Sanitation CouncilPharmaceutical and Food Safety Bureau,Ministry of Health, Labour and Welfare1-2-2, Kasumigaseki,Chiyoda-ku, Tokyo 100-8916,JapanWebsite: http://www.mhlw.go.jp/english/ (Japanese,English)E-mail: IYSINSA@mhlw.go.jp3. The Japanese opoeia/index.html (English)JP 16thJP 15th15 Supplement 115 Supplement 2JP 14th14 Supplement 114 Supplement 2JP 13th13 Supplement 113 Supplement 2JP 12th12 Supplement 112 Supplement 2JP 11th11 SupplementJP 10thtJP 9 hJP 8thJP 7thJP 6thJP 5thJP 4thJP 3rdJP 2ndJP 886Japanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, EnglishJapanese, aneseJapaneseJapaneseJapaneseJapanese
Working document QAS/11.453/Rev.2page 15KazakhstanThe State Pharmacopoeiaof the Republic ofKazakhstan (SPRK)1. & 2. Pharmacopoeial CenterThe National Center for expertise of Drugs, medicalproducts and medical equipmentMinistry of Health of the republic of Kazakhstan63, Ablai Khan Av050004 Almaty, KazakhstanWeb site:http://www.dari.kz (Russian)E-mail:farm@dari.kz1st Edition1, 2 vols2008KazakhRussianKorea(Republic of)The KoreanPharmacopoeia (KP)1. & 2. Korea Food and Drug AdministrationOsong Health Technology Administration Complex,187 Osongsaengmyeong2-ro, Gangoe-myeon,Cheongwon-gun, Chungcheongbuk-do, 363-951,KoreaWeb site:http://www.kfda.go.kr (Korean, English)E-mail: khs9270@korea.kr9th EditionSupplement 1Supplement 2Supplement 3Supplement 4Supplement 5Supplement 6Supplement 78th EditionSupplement 17th EditionSupplement 16th EditionSupplement 15th EditionSupplement 14th EditionSupplement 13rd EditionSupplement 1Supplement 22nd EditionPart IPart IISupplement 1Supplement 21st 72000199219931987198819821982197619781979Korean, EnglishCentral Pharmaceutical Affairs Council5-mosaemi-gil,Yangchun-gu,Seoul,KoreaKorea Food and Drug Administration3. The Korean Pharmacopoeiahttp://eng.kfda.go.kr (English)(from KFDA News to Relevant Rule)4. Currently revised in every 5-year term19671968196819691958
Working document QAS/11.453/Rev.2page 16LithuaniaMexico1. Pharmacopoeia CommissionState Medicines Control Agencyunder the Ministry of Health of the Republic of LithuaniaRygos str. 15,LT-05245 VilniusWeb site:http://www.vvkt.lt (Lithuanian, English)E-mail: fs.vvkt@vvkt.ltFarmacopea de losEstadosUnidos Mexicanos1. Comisión Permanente de la Farmacopea delos Estados Unidos Mexicanos,Rio Rhin 57,ColCuauhtémoc, C.P. 06500, México DF, MexicoWeb site: http://www.farmacopea.org.mx(Spanish)E-mail: cpfeum@farmacopea.org.mx2. Secretaría de Salud,Leija 7 Col. Juárez, C.P. 06696México DFMexican HerbalPharmacopoeia10th EditionSupplement9th EditionSupplement8th EditionSupplement7th EditionSupplement 1Supplement 26th EditionSupplement 1Supplement 25th EditionSupplement 1Supplement 24th Edition3rd Edition2nd Edition1st Edition(began new 95199819881990199219741962195219314th Edition3rd Edition2nd Edition1st Edition19041896188418461st Edition2001SpanishSpanish
Working document QAS/11.453/Rev.2page 17Mexican HomeopathicPharmacopoeia2nd Edition1st Edition20071998SpanishMedical devicesSupplement1st Edition2nd Edition20052011SpanishPharmacies Supplement1st Edition2nd Edition3rd Edition4th Edition19962000200520101. The Republic of Montenegro, Ministry of HealthMontenegroRimski trg 46, PC Vektra81000 Podgorica, MontenegroWeb site: http://www.mzdravlja.gov.me (Croatian,English, Serbian)E-mail: 1. Norwegian Pharmacopoeia CommissionNorwegian Medicines AgencyStatens LegemiddelverkSven Oftedals vei 8, 0950Post box 63, Kalbakken,N-0901 OsloWeb site:http://www.slv.no (Norwegian, English)E-mail: post@legemiddelverket.no
Working document QAS/11.453/Rev.2page 18PakistanPakistan Pharmacopoeia1. Pakistan Pharmacopoeia Commission,Ministry of Health(Note: The Ministry of Health was devolved to theprovinces under the 18th Amendment by the FederalGovernment on June 30th 2011)1st Edition1974English1st Edition2004EnglishDrug Control OrganizationWeb site: http://www.dcomoh.gov.pk (English)E-mail: info@dcomoh.gov.pkGovernment of PakistanWeb site: http://www.pakistan.gov.pk (English)PhilippinesPhilippine Pharmacopeia1. Products Services DivisionBureau of Food and DrugsDepartment of HealthRepublic of the PhilippinesSan Lazaro Compound, Sta. Cruz, Manila, PhilippinesWeb site: -mail: ftduque@co.doh.gov.ph
Working document QAS/11.453/Rev.2page 19PolandFarmakopea Polska1. Pharmacopoeia Commission,Pharmacopoeia Department,Office for Registration of Medicinal Products,Medical Devices & Biocidal Products;41 Ząbkowska Str.03-736 Warsaw, PolandWeb site: http://www.urpl.gov.pl (Polish, English)E-mail: president@urpl.gov.pl2. Office for Registration of Medicinal Products,Medical Devices and Biocidal Products;41 Ząbkowska Str.03-736 Warsaw, Poland3. Web site:http://www.urpl.gov.pl (Polish, English)9th Edition8th Edition (andsupplements)7th Edition (andsupplements)6th Edition5th EditionSu
Beijing 100082, P. R. China 4. once every five years 6th Edition 5th Edition 4th Edition 3rd Edition 2nd Edition 1st Edition 1995 1990 1985 1977 1963 1953 Chinese, English Chinese, English Chinese, English Chinese Chinese Chinese Croatia 1. Pharmacopoeia Commission Agency for Medicinal Products and Medical Devices of Croatia
Abbreviations xxix PC Carli price index PCSWD Carruthers, Sellwood, Ward, and Dalén price index PD Dutot price index PDR Drobisch index PF Fisher price index PGL Geometric Laspeyres price index PGP Geometric Paasche price index PH Harmonic average of price relatives PIT Implicit Törnqvist price index PJ Jevons price index PJW Geometric Laspeyres price index (weighted Jevons index)
S&P BARRA Value Index RU.S.sell Indices: RU.S.sell 1000 Growth Index RU.S.sell 2000 Index RU.S.sell LEAP Set RU.S.sell 3000 Value Index S&P/TSX Composite Index S&P/TSX Venture Composite Index S&P/TSX 60 Canadian Energy TrU.S.t Index S&P/TSX Capped Telecommunications Index Sector-based Indices: Airline Index Bank Index
WHO/EDM/QSM/2004.4 ENGLISH ONLY WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE INDEX OF PHARMACOPOEIAS The data presented in this list have been provided by national pharmacopoeia commissions.File Size: 450KB
Index numbers – Simple and weighted index numbers - Laspeyer’s and Pasche‘s index number – Fisher’s ideal index number- Marshall Edgeworth’s index number – Tests to be satisfied by an ideal index number- uses of index numbers. Recommended Texts: 1. S.P. Gupta – Statistical Methods 2.
This map does not display non-motorized uses, over-snow uses, . Fort Polk Kurthwood Cravens Gardner Forest Hill 117 28 10 107 1200 113 112 111 118 121 28 121 399 468 496 28 112 488 463 465 MAP INDEX 8 MAP INDEX 1 MAP INDEX 3 MAP INDEX 2 MAP INDEX 4 MAP INDEX 5 MAP INDEX 7 MAP I
DOW'S FIRE & EXPLOSION INDEX HAZARD CLASSIFICATION GUIDE SEVENTH EDITION a AIChE techrzical manual published by the American Institute of Chemical Engineers 345 East 47th Street, New York, NY 10017 0 1994 . C1.jpgFile Size: 788KBPage Count: 9Explore furtherDow Fire and Explosion Index (F&EI) AIChEwww.aiche.orgDOW FIRE AND EXPLOSION INDEX pdfeasystudy.infoDow Fire and Explosion Index (Dow F&EI) and Mond Indexwww.slideshare.netDow's Fire and Explosion Index Hazard Classification Guide .www.wiley.com(PDF) Dow's fire and explosion index: a case-study in the .www.researchgate.netRecommended to you based on what's popular Feedback
U.S. Debt Index Non-LendableFund F, Equity Index Non-Lendable Fund F, Russell 2500 Index Non-LendableFund F, BlackRock MSCI ACWI ex-U.S. Index Non-Lendable Fund F, Russell 1000 Index Non-Lendable Fund F This form is submitted in connection with an amendment to the Investment Agreement or a proposed consent to amend the Investment Agreement.
logic relationship between the 1D element index (the nth element) and the 1D global node indices of the vertices of the elements, through the 2D element index (the natural \row" index r e and \column" index c e of an element in the 2D mesh) and the 2D node index (the natural \row" index r n and \column" index c n of a node in the 2D mesh) 11/103
